Bladder tumor markers beyond cytology: International Consensus Panel on bladder tumor markers. - Wikidata - awgldk - TriplyDB

Bladder tumor markers beyond cytology: International Consensus Panel on bladder tumor markers.

Bladder tumor markers beyond cytology: International Consensus Panel on bladder tumor markers.

http://www.wikidata.org/entity/Q36363221

about

Comparison of Guidelines on Non-Muscle Invasive Bladder Cancer (EAU, CUA, AUA, NCCN, NICE)Biomarkers for non-muscle invasive bladder cancer: Current tests and future promise What are the currently available and in development molecular markers for bladder cancer? Will they prove to be useful in the future?Diagnostic Value of Liquid-Based Cytology in Urothelial Carcinoma Diagnosis: A Systematic Review and Meta-Analysis Urine survivin as a diagnostic biomarker for bladder cancer: a systematic review Performance of survivin mRNA as a biomarker for bladder cancer in the prospective study UroScreen CCL18 in a multiplex urine-based assay for the detection of bladder cancer Diagnostic potential of urinary α1-antitrypsin and apolipoprotein E in the detection of bladder cancer.Multiplex protein signature for the detection of bladder cancer in voided urine samples Urine-based assays for the detection of bladder cancer.Potential new urinary markers in the early detection of bladder cancer.HYAL-1 hyaluronidase: a potential prognostic indicator for progression to muscle invasion and recurrence in bladder cancer.Overexpression of UHRF1 gene correlates with the major clinicopathological parameters in urinary bladder cancer.Usefulness of the NMP22BladderChek Test for Screening and Follow-up of Bladder Cancer.ProEx C as Diagnostic Marker for Detection of Urothelial Carcinoma in Urinary Samples: A Review Metabolite marker discovery for the detection of bladder cancer by comparative metabolomics.Bladder tumor markers: from hematuria to molecular diagnostics--where do we stand?ROS generation via NOX4 and its utility in the cytological diagnosis of urothelial carcinoma of the urinary bladder Urine cytology and adjunct markers for detection and surveillance of bladder cancer.The origins of urothelial carcinoma.External validation of a multiplex urinary protein panel for the detection of bladder cancer in a multicenter cohort.IL-8 as a urinary biomarker for the detection of bladder cancer.Risk of urothelial bladder cancer in Lynch syndrome is increased, in particular among MSH2 mutation carriers.A multi-analyte assay for the non-invasive detection of bladder cancer.Medical follow-up for workers exposed to bladder carcinogens: the French evidence-based and pragmatic statement.A pilot study combining a GC-sensor device with a statistical model for the identification of bladder cancer from urine headspace.Advanced urothelial carcinoma: next-generation sequencing reveals diverse genomic alterations and targets of therapy.Urinary glycoprotein biomarker discovery for bladder cancer detection using LC/MS-MS and label-free quantification.Genomic instability in complicated and uncomplicated Egyptian schistosomiasis haematobium patients Detection of bladder cancer using novel DNA methylation biomarkers in urine sediments Rationale for an early detection program for bladder cancer Circulating miR-497 and miR-663b in plasma are potential novel biomarkers for bladder cancer Best practice in the treatment of nonmuscle invasive bladder cancer.Vascular endothelial growth factor, carbonic anhydrase 9, and angiogenin as urinary biomarkers for bladder cancer detection.Statistical consideration for clinical biomarker research in bladder cancer.Molecular diagnostic trends in urological cancer: biomarkers for non-invasive diagnosis.DAPK Promoter Methylation and Bladder Cancer Risk: A Systematic Review and Meta-Analysis.A candidate molecular biomarker panel for the detection of bladder cancer.A noninvasive multianalyte urine-based diagnostic assay for urothelial cancer of the bladder in the evaluation of hematuria Direct quantitative detection for cell-free miR-155 in urine: a potential role in diagnosis and prognosis for non-muscle invasive bladder cancer

P2860

Q26744756-1F55A167-D01E-4E07-BDF7-291616050981 Q26775990-48447243-0C2C-4474-989D-4D3BC2932C20 Q26795518-5AB9EAE4-9421-4EE7-A8D8-E6DC600006AB Q26799115-81AFD39D-3B44-45BD-94DD-D4AC60C5C9DA Q26828933-59022DA9-363E-4432-8F38-911C642A28B8 Q28482379-D9FFEEF2-4148-48CC-BF1C-DE28B20E9B14 Q28729838-2842A1D4-C8EB-4208-BBFD-0EAB24E91278 Q33581255-78DBD3FE-F8E0-40B4-B8CD-D39009EA1983 Q33581322-5AEEB2F7-81D3-45F3-899D-C2EAA1190283 Q33643957-4A321C47-D7F8-4B5C-85F1-40086211AB63 Q33657098-9C6D756A-5B35-41AC-91F0-CEFF35736986 Q33688043-A74D52BC-BA5B-4FCD-95C6-92DC76776FDE Q33692622-B6B81025-BCE4-49EF-A755-FE3A2E14777D Q33792883-2A02C193-4382-4840-8599-A9B7F37F258B Q33820634-81B52C3F-BC9E-49B8-AAE9-F0775E55912E Q33888970-752BD08F-E010-4A2F-86F2-C918108FDE74 Q33915293-8EABCD3B-7290-4056-86BC-D4B96191C0F9 Q34059983-AC9AE924-5439-4033-81B6-CEC719E1701C Q34073973-658FA917-6D16-402B-8F1F-B3BAE1D71C49 Q34121078-96CA17D0-D429-4A4B-B3E3-502690BE6640 Q34135237-8B93E043-97F2-4CD1-B99E-ED51F735DAC7 Q34258579-B2D64D21-5819-46F0-BD19-322E4AD7E449 Q34346668-FA4EFC76-B0B6-4537-90BA-F48BC5F38084 Q34456333-ABAABF44-6A6C-4B44-A284-37631F7CD90A Q34503168-B46E1F14-3502-43C0-B1CD-7F5F8D167ABD Q34828645-99A4E70B-C76C-491D-A74A-66259684B428 Q34866510-2FE0EC3A-0392-497C-821E-5E32209AB2CC Q34987865-BF60445D-C833-47E3-8C8C-5A3030FE0BB7 Q35016365-41095E09-313C-4238-81C8-D94C7D170469 Q35093755-E950E80B-6751-49A6-A1B5-59C3E625001C Q35125733-92C0101E-4C7B-459C-AC78-DA9B64CA4F70 Q35650689-512B52F2-672F-4BFE-89D7-8573C13E6719 Q35688392-F5BE43D4-B564-4BE4-A2F2-96F4A98E3FE8 Q35926074-84E8BBD8-1EB0-46DC-AD9C-D08E86E104A3 Q36124883-F097D1B9-BC3A-4636-BC8F-8DBC156168BB Q36190604-679F25AB-3193-40AB-B96A-4305156178A1 Q36209868-DD1E704C-E723-42AA-B8E4-19CA74E8E7C0 Q36509712-92B81F5E-D0D5-4E1A-823D-B94D4819A7D0 Q36513100-F352F808-41D6-48FB-A2A0-F0840B18C31B Q36772110-11A49776-A6AD-4D34-A7C4-A84B33DB807B

P2860

Bladder tumor markers beyond cytology: International Consensus Panel on bladder tumor markers.

http://www.wikidata.org/entity/Q36363221

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年学术文章

@wuu

2005年学术文章

@zh-cn

2005年学术文章

@zh-hans

2005年学术文章

@zh-my

2005年学术文章

@zh-sg

2005年學術文章

@yue

2005年學術文章

@zh

2005年學術文章

@zh-hant

name

Bladder tumor markers beyond c ...... anel on bladder tumor markers.

@ast

Bladder tumor markers beyond c ...... anel on bladder tumor markers.

@en

type

label

Bladder tumor markers beyond c ...... anel on bladder tumor markers.

@ast

Bladder tumor markers beyond c ...... anel on bladder tumor markers.

@en

prefLabel

Bladder tumor markers beyond c ...... anel on bladder tumor markers.

@ast

Bladder tumor markers beyond c ...... anel on bladder tumor markers.

@en

P1433

Q36363221-48C5632A-31E3-41B8-ABE3-75EE0826BF8C

P1476

Q36363221-A9062E07-13BD-45B0-8646-73DBF0EA47E8

P2093

Q36363221-1CA883A6-E296-4A67-AF7F-3FFB417DB48E

Q36363221-33AF214A-9C0D-4E10-BB38-2E07D4F42043

Q36363221-3FBC30AE-CC04-496A-90F7-C5899D40D4D3

Q36363221-428C8D71-0B13-4D70-AFD4-ECB4BADA04D7

Q36363221-60BA47CC-FD71-4247-99CF-7008A1711487

Q36363221-8067797A-6D3F-45B1-A42C-ECAC9F4357D1

Q36363221-82DEBB36-3259-4B0B-B20C-B06FB6FC1EFE

Q36363221-9FC134C9-255C-46FE-8EE3-BD8F9FB1B597

Q36363221-AB7518AD-10D1-447C-A10B-7527377EDB69

Q36363221-AF5DE213-46CB-4D2C-A45E-1F4FD4BDE045

P304

Q36363221-0C6D4F72-9BAD-4A84-99AE-46812E0AC6FF

P31

Q36363221-928F6DD5-A62A-4CCA-AFEE-414629480BC5

P356

Q36363221-43C1A106-E9BC-4FC3-8C8B-E5EC7CAE2E13

P407

Q36363221-C3F3686C-5588-40CD-AEA3-75BB82E085F0

P433

Q36363221-1F821621-264C-44D8-91D4-9BED5FD0D8C4

P478

Q36363221-24596F0E-FB06-4B81-80E3-2808B7B71508

P577

Q36363221-2EDAEFE2-16C0-4948-A0BA-EC9C2BACC947

P698

Q36363221-18F449E6-8975-458E-93AA-07531BA19A0A

P356

J.UROLOGY.2005.08.064

P1433

P1476

Bladder tumor markers beyond c ...... anel on bladder tumor markers.

@en

P2093

Aldo V Bono

http://www.w3.org/2001/XMLSchema#string

Bernd J Schmitz-Dräger

http://www.w3.org/2001/XMLSchema#string

Edward Messing

http://www.w3.org/2001/XMLSchema#string

George P Hemstreet

http://www.w3.org/2001/XMLSchema#string

H Barton Grossman

http://www.w3.org/2001/XMLSchema#string

Jack A Schalken

http://www.w3.org/2001/XMLSchema#string

Michael J Droller

http://www.w3.org/2001/XMLSchema#string

Michael Marberger

http://www.w3.org/2001/XMLSchema#string

Peter Goebell

http://www.w3.org/2001/XMLSchema#string

Robert H Getzenberg

http://www.w3.org/2001/XMLSchema#string

P304

35-63

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.UROLOGY.2005.08.064

http://www.w3.org/2001/XMLSchema#string

P407

P433

6 Suppl 1

http://www.w3.org/2001/XMLSchema#string

P478

66

http://www.w3.org/2001/XMLSchema#string

P577

2005-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

16399415

http://www.w3.org/2001/XMLSchema#string